Allison, Honjo win Nobel Prize in medicine for research on cancer therapy
Date created : Latest update :
James Allison of the US and Tasuku Honjo of Japan have won the 2018 Nobel Prize in Physiology or Medicine for research that has revolutionised the treatment of cancer.
"Allison and Honjo showed how different strategies for inhibiting the brakes on the immune system can be used in the treatment of cancer," the Nobel Assembly at Sweden's Karolinska Institute said in a statement on Monday, jointly awarding the prize of 9 million Swedish crowns (€870,000, $1 million) to the two scientists.
This year’s #NobelPrize constitutes a landmark in our fight against cancer. The discovery made by the two Medicine Laureates takes advantage of the immune system’s ability to attack cancer cells by releasing the brakes on immune cells. pic.twitter.com/2mppP3NT19The Nobel Prize (@NobelPrize) 1 octobre 2018
Medicine is the first of the Nobel Prizes awarded each year. The prizes for achievements in science, literature and peace were created in accordance with the will of dynamite inventor and businessman Alfred Nobel, and have been awarded since 1901.
The literature prize will not be handed out this year after the awarding body was hit by a sexual misconduct scandal.
2018 #NobelPrize laureate James P. Allison studied a protein that functions as a brake on the immune system. He realised the potential of releasing the brake and unleashing our immune cells to attack tumours. He developed this concept into a new approach for treating patients. pic.twitter.com/MWYS3DnD8nThe Nobel Prize (@NobelPrize) 1 octobre 2018
The two medicine laureates studied proteins that prevent the body and its main immune cells, known as T-cells, from attacking tumour cells effectively.
Allison, professor at the University of Texas MD Anderson Cancer Center, studied a protein that functions as a brake on the immune system and realised the potential for unleashing immune cells to attack tumours if the brake could be released.
Tasuku Honjo, awarded the 2018 #NobelPrize, discovered a protein on immune cells and revealed that it also operates as a brake, but with a different mechanism of action. Therapies based on his discovery proved to be strikingly effective in the fight against cancer. pic.twitter.com/3yn2RCtr6WThe Nobel Prize (@NobelPrize) 1 octobre 2018
Honjo, professor at Kyoto University since 1984, separately discovered a second protein on immune cells and revealed that it too operated as a brake, but with a different mechanism.
"The seminal discoveries by the two Laureates constitute a landmark in our fight against cancer," the institute said.
(FRANCE 24 with REUTERS)